Regulus (RGLS) Up as FDA Accepts IND for Kidney Disease Drug

Published on 16 May 2022 on MSN News

Regulus Therapeutics Inc. RGLS announced that the FDA has accepted the investigational new drug...

Read the rest of the article

Start tracking your investments with Statfolio

Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q2 2023 Earnings Call Transcript August 10, 2023 Oncono...

Insider Monkey via Yahoo Finance 13 Aug 2023

Onconova Therapeutics, Inc. (ONTX) came out with a quarterly loss of $0.28 per share versus the Z...

Zacks via Yahoo Finance 15 May 2023

Onconova Therapeutics, Inc. (NASDAQ:ONTX) Q4 2022 Earnings Call Transcript March 16, 2023 Operato...

Insider Monkey via Yahoo Finance 18 Mar 2023

Onconova Therapeutics Inc (NASDAQ: ONTX) announced that the second of two evaluable participants ...

Benzinga via Yahoo Finance 7 Feb 2023

Onconova Therapeutics, Inc. (ONTX) came out with a quarterly loss of $0.26 per share versus the Z...

Zacks via Yahoo Finance 14 Nov 2022

Onconova Therapeutics, Inc. (ONTX) came out with a quarterly loss of $0.19 per share versus the Z...

Zacks via Yahoo Finance 11 Aug 2022

Regulus Therapeutics Inc. RGLS announced that the FDA has accepted the investigational new drug...

MSN News 16 May 2022

Regulus Therapeutics Inc. RGLS announced that the FDA has accepted the investigational new drug (...

Zacks via Yahoo Finance 12 May 2022

Catalyst Pharmaceuticals, Inc. CPRX reported earnings of 12 cents per share in the first quarter ...

Zacks via Yahoo Finance 12 May 2022

Research Analysts’ new coverage for Tuesday, May 10th: StockNews.com began coverage on shares of...

ETF DAILY NEWS 10 May 2022